NDC 52747-620

Concept OB

Vitamin Mineral Supplement

Concept OB is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Us Pharmaceutical Corporation. The primary component is Ferrous Fumarate; Iron; Ascorbic Acid; Folic Acid; Thiamine Mononitrate; Riboflavin; Niacin; Calcium Pantothenate; Pyridoxine Hydrochloride; Biotin; Cyanocobalamin; Cupric Sulfate; Magnesium Sulfate; Manganese Sulfate; Zinc Sulfate.

• Product ID: 52747-620_6d0aebcd-c00d-48ea-9690-5c466810d4a3
• NDC: 52747-620
• Product Type: Human Prescription Drug
• Proprietary Name: Concept OB
• Generic Name: Vitamin Mineral Supplement
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2009-01-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: US Pharmaceutical Corporation
• Substance Name: FERROUS FUMARATE; IRON; ASCORBIC ACID; FOLIC ACID; THIAMINE MONONITRATE; RIBOFLAVIN; NIACIN; CALCIUM PANTOTHENATE; PYRIDOXINE HYDROCHLORIDE; BIOTIN; CYANOCOBALAMIN; CUPRIC SULFATE; MAGNESIUM SULFATE; MANGANESE SULFATE; ZINC SULFATE
• Active Ingredient Strength: 130 mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1
• Pharm Classes: Vitamin C [EPC],Ascorbic Acid [CS],Nicotinic Acid [EPC],Nicotinic Acids [CS],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Copper [CS],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 52747-620-10

10 BLISTER PACK in 1 BOX (52747-620-10) > 4 CAPSULE in 1 BLISTER PACK (52747-620-04)

• Marketing Start Date: 2009-01-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 52747-620-04 [52747062004]

Concept OB CAPSULE

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-01-01

NDC 52747-620-30 [52747062030]

Concept OB CAPSULE

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2009-01-01
• Inactivation Date: 2019-10-21

NDC 52747-620-10 [52747062010]

Concept OB CAPSULE

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2009-01-01
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
FERROUS FUMARATE	130 mg/1

OpenFDA Data

• SPL SET ID: 37992a25-68bd-4050-b936-596ddedc25a3
• Manufacturer:
  • US Pharmaceutical Corporation
• UNII:
  • R5L488RY0Q
  • W00LYS4T26
  • 568ET80C3D
  • PQ6CK8PD0R
  • E1UOL152H7
  • 68Y4CF58BV
  • TLM2976OFR
  • 2679MF687A
  • 8K0I04919X
  • 935E97BOY8
  • LRX7AJ16DT
  • 89DS0H96TB
  • 6SO6U10H04
  • P6YC3EG204
• RxNorm Concept Unique ID - RxCUI:
  • 1314666
  • 1314672

Pharmacological Class

• Vitamin C [EPC]
• Ascorbic Acid [CS]
• Nicotinic Acid [EPC]
• Nicotinic Acids [CS]
• Vitamin B6 Analog [EPC]
• Vitamin B 6 [Chemical/Ingredient]
• Analogs/Derivatives [Chemical/Ingredient]
• Vitamin B 12 [CS]
• Vitamin B12 [EPC]
• Copper [CS]
• Copper-containing Intrauterine Device [EPC]
• Decreased Embryonic Implantation [PE]
• Decreased Sperm Motility [PE]
• Inhibit Ovum Fertilization [PE]

Medicade Reported Pricing

52747062030 CONCEPT OB CAPSULE

Pricing Unit: EA | Drug Type: